Board Change • May 20
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 1 independent director (5 non-independent directors). President of the Board Guillermo Errazuriz is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. 공시 • May 03
Cementos Bio Bio S.A. announces Annual dividend, payable on May 25, 2026 Cementos Bio Bio S.A. announced Annual dividend of CLP 38.0000 per share payable on May 25, 2026, ex-date on May 19, 2026 and record date on May 18, 2026. 공시 • Mar 31
Cementos Bio Bio S.A., Annual General Meeting, Apr 29, 2026 Cementos Bio Bio S.A., Annual General Meeting, Apr 29, 2026. Location: avenida andres bello 2457, piso 18 providencia, santiago Chile Reported Earnings • Mar 12
Full year 2025 earnings released: EPS: CL$125 (vs CL$123 in FY 2024) Full year 2025 results: EPS: CL$125 (up from CL$123 in FY 2024). Revenue: CL$370.5b (up 3.1% from FY 2024). Net income: CL$33.1b (up 2.0% from FY 2024). Profit margin: 8.9% (down from 9.0% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Mar 10
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 1 independent director (5 non-independent directors). President of the Board Guillermo Errazuriz is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Board Change • Feb 04
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 1 independent director (5 non-independent directors). President of the Board Guillermo Errazuriz is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. New Risk • Nov 14
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 45% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Reported Earnings • Nov 03
Third quarter 2025 earnings released: EPS: CL$27.00 (vs CL$28.25 in 3Q 2024) Third quarter 2025 results: EPS: CL$27.00 (down from CL$28.25 in 3Q 2024). Revenue: CL$88.9b (flat on 3Q 2024). Net income: CL$7.12b (down 4.5% from 3Q 2024). Profit margin: 8.0% (down from 8.4% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 43% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Oct 20
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Sep 05
Second quarter 2025 earnings released: EPS: CL$23.00 (vs CL$24.67 in 2Q 2024) Second quarter 2025 results: EPS: CL$23.00 (down from CL$24.67 in 2Q 2024). Revenue: CL$91.9b (up 9.1% from 2Q 2024). Net income: CL$6.27b (down 3.9% from 2Q 2024). Profit margin: 6.8% (down from 7.7% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Aug 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chilean stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.0% average weekly change). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. New Risk • May 29
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 21% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Reported Earnings • May 29
First quarter 2025 earnings released: EPS: CL$22.00 (vs CL$41.56 in 1Q 2024) First quarter 2025 results: EPS: CL$22.00 (down from CL$41.56 in 1Q 2024). Revenue: CL$93.1b (down 5.0% from 1Q 2024). Net income: CL$5.91b (down 46% from 1Q 2024). Profit margin: 6.3% (down from 11% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Board Change • May 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Apr 29
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. 공시 • Mar 28
Cementos Bio Bio S.A., Annual General Meeting, Apr 30, 2025 Cementos Bio Bio S.A., Annual General Meeting, Apr 30, 2025. Location: av gran bretana n 1 725, talcahuano Chile Board Change • Mar 26
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Mar 03
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Mar 01
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. 2 independent directors (5 non-independent directors). Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. New Risk • Nov 20
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chilean stocks, typically moving 25% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Upcoming Dividend • Sep 16
Upcoming dividend of CL$23.00 per share Eligible shareholders must have bought the stock before 23 September 2024. Payment date: 26 September 2024. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of Chilean dividend payers (9.4%). Higher than average of industry peers (2.6%). Reported Earnings • Sep 02
Second quarter 2024 earnings released: EPS: CL$25.00 (vs CL$10.05 in 2Q 2023) Second quarter 2024 results: EPS: CL$25.00 (up from CL$10.05 in 2Q 2023). Revenue: CL$84.3b (up 2.0% from 2Q 2023). Net income: CL$6.52b (up 146% from 2Q 2023). Profit margin: 7.7% (up from 3.2% in 2Q 2023). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Upcoming Dividend • May 09
Upcoming dividend of CL$23.00 per share Eligible shareholders must have bought the stock before 16 May 2024. Payment date: 22 May 2024. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of Chilean dividend payers (10%). Higher than average of industry peers (3.9%). Reported Earnings • Apr 28
First quarter 2024 earnings released: EPS: CL$42.00 (vs CL$17.94 in 1Q 2023) First quarter 2024 results: EPS: CL$42.00 (up from CL$17.94 in 1Q 2023). Revenue: CL$97.8b (up 11% from 1Q 2023). Net income: CL$11.0b (up 132% from 1Q 2023). Profit margin: 11% (up from 5.4% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 01
Full year 2023 earnings released Full year 2023 results: Revenue: CL$349.0b (up 4.5% from FY 2022). Net income: CL$22.8b (up 116% from FY 2022). Profit margin: 6.5% (up from 3.2% in FY 2022). Upcoming Dividend • Dec 11
Upcoming dividend of CL$13.00 per share at 1.8% yield Eligible shareholders must have bought the stock before 18 December 2023. Payment date: 21 December 2023. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of Chilean dividend payers (12%). Lower than average of industry peers (3.4%). Reported Earnings • Dec 02
Third quarter 2023 earnings released: EPS: CL$13.00 (vs CL$9.00 in 3Q 2022) Third quarter 2023 results: EPS: CL$13.00 (up from CL$9.00 in 3Q 2022). Revenue: CL$82.9b (down 2.7% from 3Q 2022). Net income: CL$3.53b (up 48% from 3Q 2022). Profit margin: 4.3% (up from 2.8% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 2% per year. Reported Earnings • Sep 15
Second quarter 2023 earnings released: EPS: CL$10.00 (vs CL$5.27 in 2Q 2022) Second quarter 2023 results: EPS: CL$10.00 (up from CL$5.27 in 2Q 2022). Revenue: CL$82.6b (up 5.9% from 2Q 2022). Net income: CL$2.66b (up 91% from 2Q 2022). Profit margin: 3.2% (up from 1.8% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has remained flat. Upcoming Dividend • May 11
Upcoming dividend of CL$12.00 per share at 1.9% yield Eligible shareholders must have bought the stock before 18 May 2023. Payment date: 23 May 2023. Payout ratio is a comfortable 30% but the company is paying out more than the cash it is generating. Trailing yield: 1.9%. Lower than top quartile of Chilean dividend payers (13%). Lower than average of industry peers (3.4%). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Jun 02
First quarter 2022 earnings released First quarter 2022 results: Revenue: CL$77.1b (up 14% from 1Q 2021). Net income: CL$479.0m (down 89% from 1Q 2021). Profit margin: 0.6% (down from 6.2% in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Vice President of the Board Eduardo Novoa Castellon was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Mar 24
Upcoming dividend of CL$95.00 per share Eligible shareholders must have bought the stock before 30 March 2022. Payment date: 04 April 2022. Payout ratio is on the higher end at 79%, and the cash payout ratio is above 100%. Trailing yield: 19%. Within top quartile of Chilean dividend payers (9.3%). Higher than average of industry peers (4.3%). Upcoming Dividend • Nov 30
Upcoming dividend of CL$38.00 per share Eligible shareholders must have bought the stock before 07 December 2021. Payment date: 13 December 2021. Trailing yield: 8.7%. Lower than top quartile of Chilean dividend payers (9.2%). Higher than average of industry peers (4.0%). Reported Earnings • Sep 08
Second quarter 2021 earnings released The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CL$67.2b (up 35% from 2Q 2020). Net income: CL$3.04b (up 100% from 2Q 2020). Profit margin: 4.5% (up from 3.0% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Jun 17
Upcoming dividend of CL$14.00 per share Eligible shareholders must have bought the stock before 24 June 2021. Payment date: 30 June 2021. Trailing yield: 5.9%. Lower than top quartile of Chilean dividend payers (6.5%). Higher than average of industry peers (2.9%). Reported Earnings • Jun 02
First quarter 2021 earnings released: EPS CL$15.78 (vs CL$10.63 in 1Q 2020) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: CL$67.4b (down 1.4% from 1Q 2020). Net income: CL$4.17b (up 49% from 1Q 2020). Profit margin: 6.2% (up from 4.1% in 1Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Apr 16
Upcoming dividend of CL$10.00 per share Eligible shareholders must have bought the stock before 23 April 2021. Payment date: 28 April 2021. Trailing yield: 1.6%. Lower than top quartile of Chilean dividend payers (5.8%). Lower than average of industry peers (2.7%). Reported Earnings • Apr 03
Full year 2020 earnings released: EPS CL$52.09 (vs CL$49.60 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CL$242.6b (down 7.8% from FY 2019). Net income: CL$13.8b (up 5.0% from FY 2019). Profit margin: 5.7% (up from 5.0% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Jan 27
New 90-day high: CL$758 The company is up 2.0% from its price of CL$742 on 28 October 2020. The Chilean market is up 16% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Basic Materials industry, which is down 1.0% over the same period. Upcoming Dividend • Jan 23
Upcoming Dividend of CL$14.00 Per Share Will be paid on the 3rd of February to those who are registered shareholders by the 29th of January. The trailing yield of 1.6% is below the top quartile of Chilean dividend payers (5.7%), and is lower than industry peers (2.7%). Is New 90 Day High Low • Jan 04
New 90-day high: CL$754 The company is up 11% from its price of CL$682 on 06 October 2020. The Chilean market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Basic Materials industry, which is up 1.0% over the same period. Reported Earnings • Nov 30
Third quarter 2020 earnings released: EPS CL$9.87 The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: CL$50.9b (down 18% from 3Q 2019). Net income: CL$2.61b (down 27% from 3Q 2019). Profit margin: 5.1% (down from 5.7% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Oct 15
New 90-day high: CL$742 The company is up 8.0% from its price of CL$688 on 17 July 2020. The Chilean market is down 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Basic Materials industry, which is down 1.0% over the same period.